New Releases from NCBI BookshelfComparing Two Medicines for Adults with Myasthenia Gravis – The PROMISE-MG Study [Internet].​Comparing Two Medicines for Adults with Myasthenia Gravis – The PROMISE-MG Study [Internet].

Myasthenia gravis (MG) is an autoimmune neuromuscular disease caused by autoantibodies directed at the neuromuscular junction. The estimated prevalence is 14 to 40/100 000. There are no comparative effectiveness studies of immunosuppressive treatments for MG.

​